Market cap
₹5 Cr
Recently Viewed
Clear AllMarket cap
₹5 Cr
Revenue (TTM)
₹4 Cr
P/E Ratio
--
P/B Ratio
-0.3
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹-3 Cr
ROE
0 %
ROCE
-11.7 %
Industry P/E
--
EV/EBITDA
-31.7
Debt to Equity
-2.2
Book Value
₹-0.4
EPS
₹-0.1
Face value
1
Shares outstanding
534,171,427
CFO
₹-114.08 Cr
EBITDA
₹-7.79 Cr
Net Profit
₹-164.70 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Farmax India
| -- | -- | -- | -- | -50.0 | -34.0 | -- |
|
BSE Sensex*
| -9.5 | 5.5 | -6.0 | -4.3 | 8.7 | 9.9 | 11.5 |
|
BSE FMCG#
| -7.0 | 11.4 | -0.2 | -10.2 | 3.7 | 8.4 | 9.2 |
|
Company
|
2016
|
2015
|
2014
|
|---|---|---|---|
|
Farmax India
| -66.7 | -77.8 | 250.0 |
|
BSE Sensex
| 1.9 | -5.0 | 29.9 |
|
BSE FMCG
| 3.3 | 1.4 | 18.3 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Farmax India
|
0.1 | 4.8 | 4.4 | -2.8 | -44.6 | 0 | -- | -0.3 |
| 453.4 | 5,919.6 | 1,164.7 | 189.9 | 17.6 | 27.2 | 31.1 | 7.8 | |
| 460.2 | 20,087.7 | 3,817.5 | 798.5 | 21.4 | 28.6 | 25.3 | 6.2 | |
| 254.6 | 589.4 | 104.9 | 13.4 | -- | 45.4 | 44.1 | 6.3 | |
| 259.0 | 9,529.2 | 2,892.8 | 342.7 | 14.0 | 24.5 | 27.8 | 6.3 | |
| 262.6 | 402.3 | 221.4 | -75.4 | -23.1 | -- | -- | -3.0 | |
| 51.2 | 99.3 | 308.8 | 3.9 | 1.5 | 10.9 | 25.9 | 2.6 | |
| 64.2 | 156.4 | 392.0 | -4.7 | 0.9 | -2.7 | -- | 0.9 | |
| 353.5 | 790.8 | 107.5 | 16.0 | -- | 29.6 | 49.5 | 6.4 | |
| 490.9 | 15,605.8 | 3,389.4 | 207.1 | 9.5 | 4.4 | 75.4 | 2.8 |
No Review & Analysis are available.
Manufacture of grain mill products, starches and starch products
Incorporated
1995
Chairman
--
Managing Director
M Srinivasa Reddy
Headquarters
Rangareddy Dist, Telangana
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
The share price of Farmax India Ltd is ₹0.05 (NSE) and ₹0.09 (BSE) as of 02-Jul-2018 IST. Farmax India Ltd has given a return of -50% in the last 3 years.
Since, TTM earnings of Farmax India Ltd is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2017
|
0.00
|
-0.26
|
|
2016
|
0.00
|
-0.52
|
|
2015
|
0.00
|
-4.79
|
|
2014
|
0.00
|
-0.76
|
|
2013
|
0.00
|
-1.49
|
The 52-week high and low of Farmax India Ltd are Rs -- and Rs -- as of 26-Apr-2026.
Farmax India Ltd has a market capitalisation of ₹ 5 Cr as on 07-Mar-2017. As per SEBI classification, it is a company.
Before investing in Farmax India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.